Development and validation of an administrative data algorithm to estimate the disease burden and epidemiology of multiple sclerosis in Ontario, Canada

Multiple Sclerosis

Volumn 21, Issue 8, 2015, Pages 1045-1054

  Widdifield, Jessica ^a   Ivers, Noah M ^b,c   Young, Jacqueline ^a   Green, Diane ^a   Jaakkimainen, Liisa ^b,c   Butt, Debra A ^b   O'Connor, Paul ^b   Hollands, Simon ^a   Tu, Karen ^a,b,d,e  

^a INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d ST MICHAEL'S HOSPITAL   (Canada)

^e TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

Administrative database; algorithm; Canada; epidemiology; health data collection; incidence; multiple sclerosis; Ontario; prevalence; validation study

Indexed keywords

ADULT; ALGORITHM; ARTICLE; CANADA; COHORT ANALYSIS; DATA ANALYSIS; ELECTRONIC MEDICAL RECORD; FEMALE; HOSPITALIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; POPULATION RESEARCH; PREDICTIVE VALUE; PREVALENCE; SENSITIVITY ANALYSIS; VALIDATION STUDY; AGE; AGED; COST OF ILLNESS; ECONOMICS; INFORMATION PROCESSING; MIDDLE AGED; ONTARIO; PHYSICIAN; REPRODUCIBILITY; SEX DIFFERENCE; STANDARD; STATISTICS AND NUMERICAL DATA; CONTROLLED STUDY; DATA BASE; HEALTH INSURANCE; HOSPITAL BILLING;

ADULT; AGE FACTORS; AGED; ALGORITHMS; COHORT STUDIES; COST OF ILLNESS; DATA COLLECTION; FEMALE; HOSPITALIZATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; ONTARIO; PHYSICIANS; PREVALENCE; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SEX FACTORS;

EID: 84985905117     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458514556303     Document Type: Article

References (31)

1. Marrie RA, Hanwell H,. General health issues in multiple sclerosis: Comorbidities, secondary conditions and health behaviors. Continuum 2013; 19: 1046-1057.
2. Owens GM, Olvey EL, Skrepnek GH,. Perspectives for managed care organizations on the burden of multiple sclerosis and the cost-benefits of disease-modifying therapies. J Manag Care Pharm 2013; 19: S41-53.
3. Flachenecker P, Stuke K,. National MS registries. J Neurol 2008; 255: S102-108.
4. Buchanan RJ, Chakravorty BJ, Tyry T,. Age-related comparisons of people with multiple sclerosis: Demographic, disease and treatment characteristics. Neuro Rehabil 2009; 25: 271-278.
5. Marrie RA,. Administrative databases for observational studies in multiple sclerosis: Power or peril? Mult Scler 2014; 20: 1151-1152.
6. Marrie RA, Yu N, Blanchard J,. The rising prevalence and changing age distribution of multiple sclerosis in Manitoba. Neurology 2010; 74: 465-471.
7. Marrie RA, Fisk JD, Stadnyk KJ,. The incidence and prevalence of multiple sclerosis in Nova Scotia, Canada. Can J Neurol Sci 2013; 40: 824-831.
8. Beck CA, Metz LM, Svenson LW, Regional variation of multiple sclerosis prevalence in Canada. Mult Scler 2005; 11: 516-519.
9. Statistics Canada. Canadas ethnocultural portrait: The changing mosaic. Report, Statistics Canada, Canada, 2003.
10. Krysko KM, Ivers NM, Young J,. Identifying individuals with multiple sclerosis in an electronic medical record. Mult Scler 2014. pii: 1352458514538334. [Epub ahead of print]
11. Tu K, Mitiku TF, Ivers NM,. Evaluation of Electronic Medical Record Administrative data Linked Database (EMRALD). Am J Manag Care 2014; 20: 15-21.
12. Widdifield J, Bombardier C, Bernatsky S,. An administrative data validation study of the accuracy of algorithms for identifying rheumatoid arthritis: The influence of the reference standard on algorithm performance. BMC Musculoskelet Disord 2014; 15: Page 1-9. DOI: 10.1186/1471-2474-15-216.
13. Tu K, Mitiku T, Lee DS,. Validation of physician billing and hospitalization data to identify patients with ischemic heart disease using data from the Electronic Medical Record Administrative data Linked Database (EMRALD). Canad J Cardiol 2010; 26: 225-228.
14. Schultz SE, Rothwell DM, Chen Z,. Identifying cases of congestive heart failure from administrative data: A validation study using primary care patient records. Chronic Dis Inj Can 2013; 33: 160-166.
15. Tu K, Wang M, Jaakkimainen RL,. Assessing the validity of using administrative data to identify patients with epilepsy. Epilepsia 2014; 55: 335-343.
16. Tu K, Wang M, Young J,. Validity of administrative data for identifying patients who have had a stroke or transient ischemic attack using EMRALD as a reference standard. Can J Cardiol 2013; 29: 1388-1394.
17. Ontario Health Insurance Plan: The program, www.health.gov.on.ca/en/public/programs/ohip/. Toronto: Ontario Ministry of Health and Long-Term Care (2008,. Accessed: September 2014)
18. World Health Organization (WHO). International Classification of Diseases, 9th Revision, Clinical Modification. Geneva: WHO.
19. Canadian Institute for Health Information (CIHI). The CIHI data quality framework. Ottawa: CIHI, 2009.
20. Chan B, Schultz S,. Supply and utilization of general practitioner and family physician services in Ontario. Toronto: Institute for Clinical Evaluative Sciences, 2005.
21. Improving health care data in Ontario. Report, Institute for Clinical Evaluative Sciences (ICES) Investigative Report., 2005. Toronto: ICES.
22. Warren SA, Svenson LW, Warren KG,. Contribution of incidence to increasing prevalence of multiple sclerosis in Alberta, Canada. Mult Scler 2008; 14: 872-829.
23. Orton SM, Herrera BM, Yee IM,. Sex ratio of multiple sclerosis in Canada: A longitudinal study. Lancet Neurol 2006; 5: 932-936.
24. Chafe R, Born KB, Slutsky AS,. The rise of people power. Nature 2011; 472: 410-411.
25. Evans C, Beland SG, Kulaga S,. Incidence and prevalence of multiple sclerosis in the Americas: A systematic review. Neuroepidemiology 2013; 40: 195-210.
26. Trojano M, Lucchese G, Graziano G,. Geographical variations in sex ratio trends over time in multiple sclerosis. PLoS One 2012; 7: e48078.
27. Ramagopalan SV, Byrnes JK, Orton SM,. Sex ratio of multiple sclerosis and clinical phenotype. Eur J Neurol 2010; 17: 634-637.
28. Polman CH, Reingold SC, Banwell B,. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011; 69: 292-302.
29. Nightingale AL, Farmer RD, De Vries CS,. Systemic lupus erythematosus prevalence in the UK: Methodological issues when using the General Practice Research Database to estimate frequency of chronic relapsing-remitting disease. Pharmacoepidemiol Drug Saf 2007; 16: 144-151.
30. Widdifield J, Paterson JM, Bernatsky S,. The epidemiology of rheumatoid arthritis (RA) in Ontario, Canada. Arthritis Rheum 2014; 66: 786-793.
31. Ng R, Bernatsky S, Rahme E,. Observation period effects on estimation of systemic lupus erythematosus incidence and prevalence in Quebec. J Rheumatol 2013; 40: 1334-1336.